Alfa-pegylated interferons (2a and 2b) and ribavirin for treatment chronic hepatitis C, genotype 1: a cost-effectiveness analysis.

Autor:	Gonzalez Mosegui, Gabriela Bittencourt, De Mello Vianna, Cid Manso, Da Silva Rodrigues, Marcus Paulo, De Mello Perez, Renata
Předmět:	INTERFERONS RIBAVIRIN HEPATITIS C treatment DRUG efficacy COST effectiveness MARKOV processes QUALITY of life
Zdroj:	Physis: Revista de Saúde Coletiva; 2011, Vol. 21 Issue 2, p377-393, 17p, 11 Charts
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu